With 0.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.94 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $76.35 whereas the lowest price it dropped to was $68.92. The 52-week range on JXN shows that it touched its highest point at $115.22 and its lowest point at $62.81 during that stretch. It currently has a 1-year price target of $99.60. With its current market cap of 5.13 billion, JXN has annualized dividend of $2.90 while the current yield stands at 4.11%. JXN paid its most recent dividend on 1741651200, while the ex-dividend date for that was 1741651200. Beta for the stock currently stands at 1.53.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of JXN was down-trending over the past week, with a drop of -16.49%, but this was down by -13.11% over a month. Three-month performance dropped to -21.57% while six-month performance fell -26.93%. The stock gained 6.03% in the past year, while it has lost -18.98% so far this year. A look at the trailing 12-month EPS for JXN yields 11.44 with Next year EPS estimates of 22.77. For the next quarter, that number is 5.06. This implies an EPS growth rate of 11.01% for this year and 9.15% for next year.
Float and Shares Shorts:
At present, 73.38 million JXN shares are outstanding with a float of 71.15 million shares on hand for trading. On 2025-03-14, short shares totaled 3.83 million, which was 526.9999799999999 higher than short shares on 1739491200. In addition to Ms. Laura Louene Prieskorn as the firm’s CEO, President & Director, Ms. Carrie Lynn Chelko serves as its Executive VP & General Counsel.
Institutional Ownership:
Through their ownership of 0.97283 of JXN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for JXN since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With JXN analysts setting a high price target of 118.0 and a low target of 88.0, the average target price over the next 12 months is 99.6. Based on these targets, JXN could surge 67.26% to reach the target high and rise by 24.73% to reach the target low. Reaching the average price target will result in a growth of 41.18% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $19.54165 being high and $18.49457 being low. For JXN, this leads to a yearly average estimate of $19.01811. Based on analyst estimates, the high estimate for the next quarter is $5.32 and the low estimate is $5.15. The average estimate for the next quarter is thus $5.23.
